Balancing the benefits and costs of antibiotic drugs: the TREAT model.
TREAT is a computerized decision support system aimed at improving empirical antibiotic treatment of inpatients with suspected bacterial infections. It contains a model that balances, for each antibiotic choice (including 'no antibiotics'), expected benefit and expected costs. The main benefit afforded by appropriate, empirical, early antibiotic treatment in moderate to severe infections is a better chance of survival. Each antibiotic drug was consigned three cost components: cost of the drug and administration; cost of side effects; and costs of future resistance. 'No treatment' incurs no costs. The model worked well for decision support. Its analysis showed, yet again, that for moderate to severe infections, a model that does not include costs of resistance to future patients will always return maximum antibiotic treatment. Two major moral decisions are hidden in the model: how to take into account the limited life-expectancy and limited quality of life of old or very sick patients; and how to assign a value for a life-year of a future, unnamed patient vs. the present, individual patient.
Leibovici
L
L
Department of Medicine E, Beilinson Hospital, Rabin Medical Center, Petah-Tiqva, Israel. leibovic@post.tau.ac.il
Paul
M
M
Andreassen
S
S
D000465:Algorithms; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000191:economics* / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000191:economics; D002985:Clinical Protocols; D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D016527:Drug Costs; D024881:Drug Resistance, Bacterial; D017048:Health Care Costs; D006801:Humans; D008017:Life Expectancy; D011788:Quality of Life; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents